Updated on: 2020-03-28
| Response | |
|---|---|
| Q1A. What arrangements, if any, do you have in place to ensure scientific advice informs national policy and decision making in relation to Covid-19? | The Swedish Research Council has a call for research on viruses, initiated by the latest development. More actions are planned. |
| Q1B. In what ways, if any, are you coordinating on Covid-19 STI responses at international level? | None regarding research |
| Q2.Do you have dedicated arrangements in place for communicating science advice and for refuting misleading information to the public on Covid-19? | The Research councils do not have specific information activities on Covid-19. |
| Q3. What new STI policy measures, if any, is your country taking to respond specifically to the Covid-19 crisis? | Call for research funding is open. Medical universities and the research infrastructure for Life sciences, SciLifeLab, will together with private funds perform tests for Covid-19 in order to increase the national testing capacity. Commercial test-kits will be assessed for accuracy by testing them together with testing in the Health care sector. More actions are being planned. |
| Q4A. At national level, what mechanisms are you developing or relying upon to bring together different STI actors (researchers, industry, government, health sector, foundations, etc.) to effectively collaborate on responses to Covid-19? | The health sector is always in contact with research in relevant fields. The initiative by medical universities and the research infrastructure SciLifeLab will make resources and laboratories available for tests and studies on Covid-19 |
| Q4B. At international level, what mechanisms are you developing or relying upon to bring together different STI actors (researchers, industry, government, health sector, foundations, etc.) to effectively collaborate on responses to Covid-19? | None at present, but science is always international and scientists are always having contacts with colleagues in the same area. |
| Q5. What novel approaches, if any, is your country using to address the coronavirus crisis (e.g. use of machine learning, open science initiatives boosting access and sharing of data and research results, development and use of prediction models, etc.)? | Resources at medical universities are made available for the health care sector |
| Q6A. What impact on the STI system do you anticipate in the short-, medium- and long-term, and what measures are you implementing to address those? | Increased funding will give more research. |
| Q6B. Is support of the STI system part of planned stimulus packages aimed at supporting the economy? | Too early to answer |
| Q7. Is there anything else regarding the STI policy response to Covid-19 in your country you would like to mention? | [Left blank] |